Osteopenia Completed Phase 2 Trials for Zoledronic acid (DB00399)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01228318Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)Treatment